• 1
    Parkin DM, Muir CS Whelan SL, et al. Cancer incidence in five continents. Comparability and quality of data. IARC Sci Publ. 1992; 120: 45173.
  • 2
    Devilliers EM. Heterogeneity of the human papillomavirus group. J Virol. 1989; 63: 48984903.
  • 3
    Munoz N, Bosch FX. Current views on the epidemiology of HPV and cervical cancer. In: LaceyC, editor. Papillomavirus reviews: current research on papillomavirus. London: Leeds University Press, 1996: 227237.
  • 4
    Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer. A worldwide perspective. J Natl Cancer Inst. 1995; 87: 796802.
  • 5
    Brown DR, McClowry TL, Woods K, Fife KH. Nucleotide sequence and characterization of human papillomavirus type 83, a novel genital papillomavirus. Virology. 1999; 260: 165172.
  • 6
    Herrero R, Hildesheim A, Bratti C, et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst. 2000; 92: 464474.
  • 7
    Cox JT, Lorincz AT, Schiffman MH, et al. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol. 1995; 172: 946954.
  • 8
    Cuzick J, Szarewski A, Terry G, et al. Human papillomavirus testing in primary cervical screening. Lancet. 1995; 345: 15331537.
  • 9
    Nobbenhuis M, Meijer CJLM, van den Brule AJC, et al. Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia. Br J Cancer. 2001; 84: 796801.
  • 10
    Bosch FX, Munoz N, De Sanjose S, et al. Risk factors for cervical cancer in Colombia and Spain. Int J Cancer. 1992; 52: 750758.
  • 11
    Becker TM, Wheeler CM, McGough NS, et al. Sexually transmitted diseases and other risk factors for cervical dysplasia among Southwestern Hispanic and non-Hispanic white women. JAMA. 1994; 271: 11811188.
  • 12
    Wright TC, Kurman RJ. A critical review of the morphologic classification systems of preinvasive lesions of the cervix. The scientific basis for the paradigm. In: LaceyC, editor. Papillomavirus reviews: current research on papillomavirus. London: Leeds University Press, 1994: 215225.
  • 13
    Lungu O, Sun XW, Felix J, et al. Relationship of human papillomavirus type to grade of cervical intraepithelial neoplasia. JAMA. 1992; 267: 24932496.
  • 14
    Kalantari M, Karlsen F, Johansson B, et al. Human papillomavirus findings in relation to cervical intraepithelial neoplasia grade: a study on 476 Stockholm women, using PCR for detection and typing of HPV. Hum Pathol. 1997; 28: 899904.
  • 15
    Takahashi Y, Yamade I, Nakamura T, et al. Infection by human papillomavirus types 6, 11, 16, 18, 31, 33 and 35 of the cervix in Japanese women. Int J Gynecol Cancer. 1995; 5: 4548.
  • 16
    Genest DR, Stein L, Cibas E, et al. A binary (Bethesda) system for classifying cervical cancer precursors: criteria, reproducibility, and viral correlates. Hum Pathol. 1993; 24: 730736.
  • 17
    Fife KH, Cramer HM, Schroeder JM, Brown DR. Detection of multiple human papillomavirus types in the lower genital tract correlates with cervical dysplasia. J Med Virol. 2001; 64: 550559.
  • 18
    Lorincz AT, Temple GF, Kurman J, et al. Oncogenic association of specific human papillomavirus types with cervical neoplasia. J Natl Cancer Inst. 1987; 79: 671677.
  • 19
    Bergeron CA, Ferenczy A, Sah KV, Naghashfar Z. Multicentric human papillomavirus infections of the female genital tract: correlation of viral types with abnormal mitotic figures, colposcopic presentation, and location. Obstet Gynecol. 1987; 69: 736742.
  • 20
    Crum CP, Mitao M, Levine RU, Silverstein SJ. Cervical papillomaviruses segregate within morphologically distinct precancerous lesions. J Virol. 1985; 54: 657681.
  • 21
    Reid RM, Greenberg AB, Jenson M, et al. Sexually transmitted papillomaviral infections. I: the anatomic distribution and pathologic grade of neoplastic lesions associated with different viral types. Am J Obstet Gynecol. 1987; 156: 212222.
  • 22
    Schneider A, Kraus H, Schuhmann R, Gissmann L. Papillomavirus infection of the lower genital tract: detection of viral DNA in gynecological swabs. Int J Cancer. 1985; 35: 443448.
  • 23
    ALTS Group. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. J Natl Cancer Inst. 2000; 92: 397.
  • 24
    Travers H. Quality assurance indicators in anatomic pathology. Arch Pathol Lab Med. 1990; 114: 11491156.
  • 25
    Solomon D, Schiffman M, Tarone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J Natl Cancer Inst. 2001; 93: 293299.
  • 26
    Schneider A, Hoyer H, Lotz B, et al. Screening for high-grade cervical intra-epithelial neoplasia and cancer by testing for high-risk HPV, routine cytology or colposcopy. Int J Cancer. 2000; 20; 89: 529534.
  • 27
    Petry KU, Bohmer G, Iftner T, Flemming P, Stoll M, Schmidt RE. Human papillomavirus testing in primary screening for cervical cancer of human immunodeficiency virus-infected women, 1990–1998. Gynecol Oncol. 1999; 75: 427431.